Research News and Research

RSS

Pfizer to join SGC-led collaboration to generate chemical probes for proteins involved in epigenetic signalling

The Structural Genomics Consortium (SGC) and Pfizer today announced that Pfizer will join the SGC-led public-private collaboration to generate small molecule inhibitors - "chemical probes" - for proteins involved in epigenetic signalling.

11 Jun 2010

Study offers new insights into how brain chooses between behaviors that are critical for survival

A team of biologists has isolated genes that regulate the sleep-feeding conflict. The study, which appears in the latest issue of the journal Current Biology, offers new insights into how the brain chooses between behaviors that are critical for survival.

11 Jun 2010

LSTM designated WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases

The World Health Organization (WHO), in consultation with the government of the United Kingdom, has designated the Liverpool School of Tropical Medicine (LSTM) as a WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases.

11 Jun 2010

Ashikari Breast Center to participate in TARGiT intra-operative radiotherapy trial

The Ashikari Breast Center at The Dobbs Ferry Pavilion of St. John's Riverside Hospital today announced its participation in two new groundbreaking studies that may alter the care for early breast cancer.

11 Jun 2010

Ginkgo extract EGb 761 promotes formation of new nerve cells, cell connections in brain's memory center

US scientists have shown that the Ginkgo extract EGb 761® promotes the formation of new nerve cells and new cell connections in the hippocampus, the brain's memory center. According to Professor Yuan Luo from the University of Maryland, Baltimore, the Ginkgo constituents responsible for these effects are quercetin and bilobalide.

11 Jun 2010

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

Innovaro, a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC, and Trojantec Ltd, a London and Cyprus based biopharmaceutical company.

11 Jun 2010

Helix BioPharma third-quarter revenues increase 20.6%

Helix BioPharma Corp. today announced financial results for the third quarter ended April 30, 2010.

11 Jun 2010

Sharron Davies unveils new Nottingham Respiratory BRU Clinical Trials Unit

Olympic swimmer and television personality Sharron Davies MBE was in Nottingham this week to open a new clinical trials unit that will take treatments for respiratory illnesses such as asthma from laboratory bench to bedside.

11 Jun 2010

Botox reduces short-term pain in thoracic outlet syndrome patients

Made popular for its ability to smooth wrinkles when injected into the face, Botox - a toxin known to weaken or paralyze certain nerves and muscles - may have another use that goes beyond the cosmetic.

11 Jun 2010

Type 2 diabetes doubles risk of cancer in women

Type 2 adult-onset diabetes causes insulin-like hormones to circulate through the body. A new study finds this has a surprisingly positive effect on reducing the rate of prostate cancer in men, but is bad news for women: Type 2 diabetes may double the risk of female genital and other cancers.

11 Jun 2010

Study identifies mechanism that interrupts normal p53 gene function leading to tumor development

The p53 gene has been a well-documented player in the prevention of tumors. It is considered the most frequently mutated gene in human tumors with more than half harboring p53 mutations (Bennett et al., 1999). These mutations often can be caused by disruption in normal p53 function.

11 Jun 2010

Bevacizumab increases risk for proteinuria in cancer patients

Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment. This conclusion stems from a study of more than 12,000 patients by Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center. Their findings are reported in online June 10 in the Journal of the American Society Nephrology (JASN).

11 Jun 2010

Medidata extends Rave EDC platform with Targeted SDV

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today introduced Rave Targeted SDV, the newest extension to its Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) solution. Rave Targeted SDV provides clinical research sponsors and contract research organizations (CROs) with an auditable and scalable partial source document verification (SDV) solution that supports risk-based site monitoring strategies.

11 Jun 2010

Shenzhen Beike Biotechnology forms joint venture with SiriCell Technologies

Shenzhen Beike Biotechnology Co. Ltd., China's leading stem cell research and regenerative medicine company, announced the formation of Beike Holdings Limited a joint venture with Bangkok-based SiriCell Technologies, Inc. Beike Holdings, which is headquartered in Bangkok, Thailand, will focus primarily on the establishment of new international subsidiaries and the development of collaborative hospital partnerships with Southeast Asia's leading healthcare providers.

11 Jun 2010

Phase 3 AVERROES clinical trial of apixaban for atrial fibrillation closes early due to clear evidence of efficacy

Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.

11 Jun 2010

FDA advisory committee recommends approval of Novartis' FTY720 for relapsing MS

Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.

11 Jun 2010

Dim and demented under the influence of cannabis

New research shows what many Cannabis users have suspected or known for a while, continuous use can lead to dimmer brains. Australia ranks among the world's highest cannabis users and this puts the population at a high risk of developing dementia say researchers.

10 Jun 2010

Gambling addiction can be inherited equally by sons and daughters: Study

Gambling is linked to a gene that is passed on through generations and a new study claims that it is passed on to both sons and daughters alike. The study published in the June issue of Archives of General Psychiatry says, that genes rule at least 50 percent of a persons propensity to gamble irrespective of sex. Genes have been linked earlier to gambling but this is the first time women are also said to inherit the trait.

10 Jun 2010

Young adult men more vulnerable to heart breaks: Study

A new study published in the international Journal of Health and Social Behaviour has shown that a bad or broken relationship affects men more than women contrary to popular belief.

10 Jun 2010

Chiltern CRO announces launch of Collaborative Technologies

Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced the launch of Collaborative Technologies.

10 Jun 2010

Research News and Research

Pfizer to join SGC-led collaboration to generate chemical probes for proteins involved in epigenetic signalling

Study offers new insights into how brain chooses between behaviors that are critical for survival

LSTM designated WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases

Ashikari Breast Center to participate in TARGiT intra-operative radiotherapy trial

Ginkgo extract EGb 761 promotes formation of new nerve cells, cell connections in brain's memory center

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

Helix BioPharma third-quarter revenues increase 20.6%

Sharron Davies unveils new Nottingham Respiratory BRU Clinical Trials Unit

Botox reduces short-term pain in thoracic outlet syndrome patients

Type 2 diabetes doubles risk of cancer in women

Study identifies mechanism that interrupts normal p53 gene function leading to tumor development

Bevacizumab increases risk for proteinuria in cancer patients

Medidata extends Rave EDC platform with Targeted SDV

Shenzhen Beike Biotechnology forms joint venture with SiriCell Technologies

Phase 3 AVERROES clinical trial of apixaban for atrial fibrillation closes early due to clear evidence of efficacy

FDA advisory committee recommends approval of Novartis' FTY720 for relapsing MS

Dim and demented under the influence of cannabis

Gambling addiction can be inherited equally by sons and daughters: Study

Young adult men more vulnerable to heart breaks: Study

Chiltern CRO announces launch of Collaborative Technologies

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News